Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00360243
Status:
COMPLETED
Last Update Posted:
2016-06-27
First Post:
2006-08-03
Brief Title:
6-mo Min Eff Dose of Flibanserin 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
Sponsor:
Sprout Pharmaceuticals Inc
Organization:
Sprout Pharmaceuticals Inc
Study Overview
Official Title:
6-mo Min Eff Dose of Flibanserin 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
Status:
COMPLETED
Status Verified Date:
2016-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder HSDD that meet standard diagnostic criteria Efficacy for flibanserin will be assessed vs a parallel placebo group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None